ArticleJournal of scleroderma and related disorders2022

Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control.

Elisa Fiorentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.